Prototype medical device engineered to deliver sustained, sub-psychedelic quantities of candidate DMT-analogues In vitro, time dependent drug elution profile evaluated for three candidate molecules Biocompatibility of drug-loaded medical device demonstrates cell-based safety at doses anticipated […]
Manufacturing Contract with the Toronto Institute of Pharmaceutical Technology VANCOUVER, BC, April 7, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics […]
Detroit, Michigan, April 07, 2022 — Artificial Intelligence Technology Solutions, Inc., (OTC: AITX), today announced that its wholly owned subsidiary Robotic Assistance Devices, Inc. (RAD) has received an order for 4 ROSA security robots from one […]
Results from Planned Interim Analysis Expected First Quarter 2023 A Positive Outcome in RESILIENT Together with Results from Previous Positive Phase 3 Study RELIEF May Support Submission of an NDA CHATHAM, N.J., April 07, 2022 […]
TORONTO, April 06, 2022—-Nextech AR Solutions Corp. (“Nextech” or the “Company”) (OTCQB: NEXCF) (NEO: NTAR) (CSE: NTAR) (FSE: N29), a Metaverse Company and leading provider of augmented reality (“AR”) experience technologies and services is pleased […]
ORAGIN makes stock option grant to a director of the Company with significant industry experience who will take an active role in the development and growth of the Company and its subsidiary Future of Cheese […]
The Company also Endorses the SEC’s Ground-Breaking Proposal to Implement a Rule that Would Require all Public Companies to Report Their Carbon Emissions CALGARY, AB, April 6, 2022 – DeepMarkit Corp., (“DeepMarkit” or the “Company”) (TSXV: MKT) […]
A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments MONTREAL, April 05, 2022 — Sunshine Biopharma, Inc. (NASDAQ: SBFM), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, […]
Company recorded revenues of approximately $400,000 in the month of March Melbourne, FL, April 04, 2022 — Kona Gold Beverage, Inc. (OTC: KGKG), a holding company focused on product development in the better-for-you and hemp […]
FORT LAUDERDALE, Fla. and HOUSTON, April 4, 2022 /PRNewswire/ — Clinigence Holdings, Inc. (“Clinigence” or the “Company”) (OTC: NUTX), a primary care-centric, technology-enabled, risk-bearing population health management company, and Nutex Health Holdco LLC (“Nutex Holdco”), together with its affiliates […]
The Formation of the Special Advisory Board Strengthens and Guides the Company’s Mission to Democratize Access To Global Carbon Credit Markets CALGARY, AB, March 29, 2022 – DeepMarkit Corp., (“DeepMarkit” or the “Company”) (TSXV: MKT) (OTC: MKTDF) (FRA: DEP), a […]
Committed to the ‘pipeline-in-a-pill’ approach with PD-001 for certain cancers and COVID-19 Advances cGMP manufacturing of clinical drug supply with Southwest Research Institute Receives final positive data for recently conducted prostate cancer model and evaluates […]
Additionally, data associated with the GeneStrat® ddPCR™ and Genestrat NGS™ blood tests will be presented at the American Association for Cancer Research (AACR) BOULDER, Colo., March 29, 2022–Biodesix, Inc. (NASDAQ: BDSX), a leading data-driven diagnostic solutions company with […]
Mr. Merson has held executive leadership positions at some of the most recognized food and beverage brands including Danone, Coca-Cola, Glaceau, Boxed Water, ZICO, and currently serves as VP for the U.S. plant-based brand SIMULATE. […]
VANCOUVER, BC, March 23, 2022 – Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) (“NOVA” or the “Company”), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is proud to announce […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
